Bevacizumab plus FOLFOX or FOLFIRI regimens on patients with unresectable liver-only metastases of metastatic colorectal cancer

BACKGROUND: The present study was aimed to evaluate the efficacy and safety of at least three cycles of Bevacizumab in combination with chemotherapy regimens, FOLFIRI or FOLFOX to treat liver metastatic colorectal cancer and improved response rates in these patients. MATERIALS AND METHODS: In this n...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Adv Biomed Res
Main Authors: Mehrzad, Valiollah, Roayaei, Mahnaz, Peikar, Mohammad Saleh, Nouranian, Elham, Mokarian, Fariborz, Khani, Mohsen, Farzannia, Somaieh
Format: Artigo
Sprog:Inglês
Udgivet: Medknow Publications & Media Pvt Ltd 2016
Fag:
Original Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4770632/
https://ncbi.nlm.nih.gov/pubmed/26962512
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2277-9175.175243
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker